Rahmet GÜNER, Bircan KAYAASLAN, Adalet ALTUNSOY AYPAK, İmran HASANOĞLU, Ayşe KAYA KALEM, Fatma ESER, Esragül AKINCI, Belgin COŞKUN, Müge AYHAN, Elif Mukime SARICAOĞLU, Yeşim AYBAR BİLİR, Burcu ÖZDEMİR

Obezitenin COVID-19 Seyrine Etkisi

Amaç: Klinik özellikler ve risk faktörleri, Koronavirüs hastalığı-2019 (COVID-19) için oldukça değişkendir. Ağır hastalığa yakalanma ve ölme riski yüksek olan kişileri öngörmek için çeşitli araştırmalar yapılıyor. Bu çalışmanın amacı obezitenin COVID-19 seyrine etkisini incelemektir. Gereç ve Yöntem: Laboratuvarca doğrulanmış COVID-19’u olan hastalar, 11 Mart ile 30 Nisan tarihleri arasında retrospektif olarak tarandı. Yatışta antropometrik ölçümlerden boy ve vücut ağırlığı ölçüldü. Vücut kitle indeksi (VKİ) hesaplandı ve hastalar Türkiye obezite tanı ve tedavi kılavuzlarına göre VKİ

The Effect of Obesity on COVID-19 Course

Objectives: Clinical features and risk factors are highly variable for Coronavirus disease-2019 (COVID-19). Researchers investigate for the prediction of people who have high risk of developing severe illness and dying. The aim of this study is to examine the effect of obesity on the course of COVID-19. Materials and Methods: Patients with laboratory confirmed COVID-19 were retrospectively screened between March 11 and April 30. Anthropometric measures including standing height and body weight were measured at admission. Body mass index (BMI) was calculated and patients were classified into three groups as BMI

PDF

___

1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.
2. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242.
3. Lighter J, Phillips M, Hochman S, et al. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020;71:896-897.
4. Simonnet A, Chetboun M, Poissy J, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver Spring). 2020;28:1195- 1199.
5. Organization WH. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.
6. Van Kerkhove MD, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8:e1001053.
7. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. MedRxiv. 2020.
8. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes (Lond). 2013;37:333-340.
9. Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J. 2006;13:203-210.
10. Martí A, Marcos A, Martínez JA. Obesity and immune function relationships. Obes Rev. 2001;2:131-140.
11. Koch A, Sanson E, Voigt S, et al. Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care. 2011;26:166-174.
12. Festa A, D’Agostino R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25:1407-1415.
13. Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020;21:e13034.
14. Xu L, Lam TH, Jiang CQ, et al. Adiposity and incident diabetes within 4 years of follow-up: the Guangzhou Biobank Cohort Study. Diabet Med. 2017;34:1400-1406.
15. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14:395-403.